Research Projects

a deeper dive into

our research projects

For over 20 years, biolution has been successful in acquiring many EU and nationally-funded research projects. We're not only proud of the work we do but also of being able to help research projects take off. Below you can see biolution's project overview and also a few select projects in more detail.

biolution project overview

 

  1. 2006
  2. 2007
  3. 2013
  4. 2017
  5. 2021
  6. 2021

  1. FP6

    From 2006 until 2011 biolution was a partner for the Mimovax project. The project started in October 2006 and ended in December 2011 with 2.4 Million euro from the EC and a 2 Million euro contribution by the participating SME.

  2. FP7

    From 2007 until 2013 Biolution was partner to many successful EU grants under the Framework Program 7. These included proposal support and project management alongside a full graphic and media design service.

  3. Horizon 2020

    Under the new EU funding scheme Horizon 2020, biolution was involved in varying levels in many projects and grants.

  4. National Grants

    From 2017 biolution was also successful in achieving three nationally funded grants with an SFB and two at the Ludwig Boltzmann institute.

  5. Horizon Europe

    After the success of Horizon 2020, 2021 saw biolution continue with three new ERC grants and the launch of FANTOM, an EU funded project comprising of 7 beneficiaries and 12 associated partners in 5 EU countries.

  6. National grants

    From 2021 until now we are also partnering on projects on a national level, including the newly formed Cluster of Excellence.

“THE SUPPORT BY BIOLUTION WAS HELPFUL DURING STAGE ONE OF THE CALL,
BUT ABSOLUTELY ESSENTIAL TO OBTAIN OUR H2020 GRANT IN STAGE TWO.”

Prof. Henry Völzke, Coordinator of EUthyroid. MD University Greifswald, Germany 

 

Selected success stories

Our work is important to us, and we are proud to have been an integral part of many EU and national research projects. Below are three projects where we have taken an active role in providing project management, as well as media and graphic design support. Our research project support is conducted before, during, and after the project funding, providing you with a complete and comprehensive service. You can find out more information about each project after clicking through to the dedicated page. If you would like to find out more about how biolution can help you navigate your research project funding, read more on our Project Management page.

SYSVASC

EU-FP7 research project to identify molecular targets for vascular disease treatment. sysVASC has made substantial progress towards identifying molecular targets of cardiovascular disease and a specialised knowledge base will aid future research.

more
SYMPATH

The SYMPATH project was initiated to address two synucleinopathies for which no causal therapy exists, namely Parkinson’s disease (PD) and Multiple System Atrophy (MSA). Ultimately, both lead to patient disability and death, which along with the number of affected individuals (PD) and the age of disease onset (MSA, PD), define their high medical need status.

more
EUthyroid

EUthyroid is the first pan-European initiative to take on the challenge of investigating the iodine intake of the European population. This should provide the basis to develop appropriate measures for harmonizing and improving the iodine intake in Europe in cooperation with national authorities.

more

"Invaluable help and support"

"Invaluable help and support covering from the ‘concept’ to the ‘writing’. Helping to drive a ‘good idea’ to a ‘fully competitive project’, being able to learn on how to design and write a grant application to be successful. Fully recommended."

Fatima Crispi
Hospital Clínic de Barcelona · Servicio de Medicina Materno Fetal Consultant and senior researcher

"highly motivated team of biolution"

“The SYMPATH cycle event was a great success, not least due to the highly motivated team of biolution.”

Prof. Achim Schneeberger, MD
AFFiRiS AG, Vienna, Austria Coordinator of SYMPATH

"very happy that biolution assists us"

“We are very happy that biolution assists us in the public outreach elements of our successful ITN “ALKATRAS”, in particular in the design and maintenance of our website.”

Dr. Suzanne Turner
University of Cambridge, UK Senior Lecturer

"important contributions"

“I enjoyed working with Stefan Grünert of biolution, who made important contributions to the funded proposal of our Ludwig Boltzmann Institute.”

Prof. Kaan Boztug, MD
CeMM, Vienna, Austria Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases

"We found a competent partner "

“With biolution we found a competent partner in Life Sciences, who took care of all aspects to organize the event for GEHC – selection of venue, registration, billing, travel arrangement, catering, filming etc. We were very satisfied, with the services provided and will engage biolution next time again.”

Florian Koelle, DI
GE Healthcare Europe GmbH, Life Sciences, Austria Teamleader Biacore Systems DACH & PL

"specific, helpful and valuable"

“We have worked together with biolution on several EU project proposals, and their input has always been very specific, helpful and valuable”.

Mag. Dr. Carolin Auer
Medical University of Graz, Austria Head of Unit for Research Management

"absolutely essential"

“The support by biolution was helpful during stage one of the call, but absolutely essential to obtain our H2020 grant in stage two.”

Prof. Henry Völzke, MD
University Greifswald, Germany Coordinator of EUthyroid

"extensive skill and experience"

"We faced several unexpected challenges during our project, and I am grateful biolution was always there to support us with their extensive skill and experience."

Prof. Gabor Kovacs, MD
Coordinator of DEVELAGE, Medical University Vienna, Austria
Collaborate

Want To Work With US? Leave Us a Message!

    biolution

    biolution offers a state-of-the-art pipeline to generate scientifically accurate 3D models as a basis for instructive visualizations, which support engagement and create interest.